ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
67,650.55
0.25%
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs Yen
157.2625
0.01%
Brent Oil
81.295
0.00%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
銘柄名/コード:
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/06/0121 : 10Business WireNuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual MeetingNYSE:NUVBPanacea Acquisition Corp
2024/06/0121 : 05GlobeNewswire Inc.Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual MeetingNASDAQ:YMABY mAbs Therapeutics Inc
2024/06/0121 : 05PR Newswire (US)Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024NASDAQ:JAZZJazz Pharmaceuticals PLC
2024/06/0121 : 01Alliance NewsAlliance NewsEXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood TechLSE:TGRTirupati Graphite Plc
2024/06/0121 : 01Alliance NewsAlliance NewsEXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood TechLSE:TPXTpximpact Holdings Plc
2024/06/0121 : 01Alliance NewsAlliance NewsEXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood TechLSE:PIERBrighton Pier Group Plc (the)
2024/06/0121 : 01Alliance NewsAlliance NewsEXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood TechLSE:LPALpa Group Plc
2024/06/0121 : 01Alliance NewsAlliance NewsEXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood TechLSE:PINEPinewood Technologies Group Plc
2024/06/0121 : 01Alliance NewsAlliance NewsEXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood TechLSE:PYCPhysiomics Plc
2024/06/0121 : 01Alliance NewsAlliance NewsEXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood TechLSE:TAVITavistock Investments Plc
2024/06/0121 : 01Alliance NewsAlliance NewsEXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood TechLSE:RTOPRegtech Open Project Plc
2024/06/0121 : 01Alliance NewsAlliance NewsEXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood TechLSE:RTOPRegtech Open Project Plc
2024/06/0121 : 00NEWSBTC$2.5 Billion In Bitcoin Flows Out Of Centralized Exchanges – Time To Buy?COIN:QNTUSDQuant
2024/06/0121 : 00NEWSBTC$2.5 Billion In Bitcoin Flows Out Of Centralized Exchanges – Time To Buy?COIN:TRXUSDTRON
2024/06/0121 : 00NEWSBTC$2.5 Billion In Bitcoin Flows Out Of Centralized Exchanges – Time To Buy?COIN:FLOWUSDFlow
2024/06/0121 : 00NEWSBTC$2.5 Billion In Bitcoin Flows Out Of Centralized Exchanges – Time To Buy?COIN:ETHUSDEthereum
2024/06/0121 : 00NEWSBTC$2.5 Billion In Bitcoin Flows Out Of Centralized Exchanges – Time To Buy?COIN:BTCUSDBitcoin
2024/06/0121 : 00Business WireMassive Bio to Unveil Drug Utilization Optimizer (DUO) at ASCO Annual Meeting 2024
2024/06/0121 : 00GlobeNewswire Inc.Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin) Monotherapy In Patients With Advanced Solid Tumors At ASCO 2024NASDAQ:MOLNMolecular Partners AG
2024/06/0121 : 00GlobeNewswire Inc.CryptoHeap Targets Top Position in Crypto Staking Industry Before Bull Run Concludes
2024/06/0121 : 00Business WirePfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/​Refractory Diffuse Large B-cell Lymphoma (DLBCL)NYSE:PFEPfizer Inc
2024/06/0121 : 00Business WireKRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung CancerNYSE:BMYBristol Myers Squibb Co
2024/06/0121 : 00Business WireGilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI CancersNYSE:RCUSArcus Biosciences Inc
2024/06/0121 : 00GlobeNewswire Inc.Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual MeetingNASDAQ:KYMRKymera Therapeutics Inc
2024/06/0121 : 00Business WireTakeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin LymphomaNYSE:PFEPfizer Inc
2024/06/0121 : 00Business WireIvonescimab Manuscript for HARMONi-A Clinical Trial Results Published in JAMANASDAQ:SMMTSummit Therapeutics Inc
2024/06/0121 : 00Business WireGilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI CancersNYSE:RCUSArcus Biosciences Inc
2024/06/0121 : 00Business WireAccutar Biotechnology Presents Phase 1 Data of AC699 Monotherapy in Patients with ER+ / HER2- Breast Cancer at ASCO 2024
2024/06/0121 : 00GlobeNewswire Inc.OkayCoin CEO Releases Key Strategies to Maximize Investor Returns on Staking Platform
2024/06/0121 : 00Business WireGilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI CancersNASDAQ:GILDGilead Sciences Inc

最近閲覧した銘柄

FX
USDEUR
US Dollar vs Euro
AMEX
SPY
SPDR S&P 500
NYSE
DIS
Walt Disney
COIN
ETHUSD
Ethereum
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
BAC
Bank of America
AMEX
XLV
Health Care Select Sector
NYSE
AXP
American Express
USI
USTECH100
US Tech 100
NASDAQ
NVDA
NVIDIA
PM
XAUUSD
Gold vs US Dollar
FX
USDJPY
US Dollar vs Yen
CCOM
US30
US 30
NYSE
NKE
Nike
USOTC
BNPQY
BNP Paribas (QX)
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有